KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Biology / 2020 / Cilt: 44 - Sayı: 1

The effect of R547, a cyclin-dependent kinase inhibitor, on hepatocellular carcinoma cell death

Gökhan KUŞ
Hatice Mehtap KUTLU
Betül HACIOĞLU
Selda KABADERE
Sayfa
24–33
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, with the same R547 doses the live Hep G2 cell percentages were92%, 101%, 53.6% (P

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Hepatocellular carcinoma (HCC) is the third main cause of cancer-related death.
📊
Temel Bulgular & Veri:Since inhibition of CDKs gives some guiding ideas for cancer studies, we aimed to determine thepossible effects of R547, a cyclin kinase 1-2-4 inhibitor, on proliferation and apoptotic mechanisms of Hep G2 cells (human) and H-4-II-E cells derived from rat HCC.
💡
Sonuç & Katkı:However, with the same R547 doses the live Hep G2 cell percentages were92%, 101%, 53.6% (P
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Hepatocellular carcinoma (HCC) is the third main cause of cancer-related death. Cyclin-dependent kinases (CDKs) and theircyclin partners regulate the cell cycle. Since inhibition of CDKs gives some guiding ideas for cancer studies, we aimed to determine thepossible effects of R547, a cyclin kinase 1-2-4 inhibitor, on proliferation and apoptotic mechanisms of Hep G2 cells (human) and H-4-II-E cells derived from rat HCC. We determined in vitro survival rates with MTT assay, apoptosis with flow cytometry, morphologicalchanges with confocal microscopy, and ultrastructural changes by transmission electron microscopy. Cisplatin was used as a positivecontrol. After 24 h of culture with 0.1, 1, 10, 50, and 100 µM doses of R547, the corresponding percentages of live Hep G2 cells were101%, 94%, 93%, 89%, and 79% (P < 0.001), respectively. However, with the same R547 doses the live Hep G2 cell percentages were92%, 101%, 53.6% (P

🔖

Bu Makaleye Atıf Yap

KUŞ, G., KUTLU, H. M., HACIOĞLU, B., KABADERE, S. (2022). The effect of R547, a cyclin-dependent kinase inhibitor, on hepatocellular carcinoma cell death. Turkish Journal of Biology, Cilt: 44 - Sayı: 1, 24–33. https://ajindex.com/articles/600169

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (6)

  1. Bollard J, Miguela V, Ruiz de Galarreta M, Venkatesh A, Bian CB et al. (2017). Palbociclib (PD-0332991), a selective CDK4 / 6 inhibitor, restricts tumour growth in preclinical models of hepatocellular carcinoma. Gut 66 (7): 1286-1296. doi: 10.1136/ gutjnl-2016-312268
  2. Cho SJ, Lee SS, Kim YJ, Park BD, Choi JS et al. (2010). Xylocydine, a novel CDK inhibitor, is an effective inducer of apoptosis in hepatocellular carcinoma cells in vitro and in vivo. Cancer Letters 287 (2): 196-206. doi: 10.1016/j.canlet.2009.06.011 De Pinto W, Chu XJ, Xuefeng Y, Smith M, Packman K et al. (2006). In vitro and in vivo activity of R547: A potent and selective cyclindependent kinase inhibitor currently in phase I clinical trials. Cancer Therapy 5 (11): 2644-2658. doi: 10.1158/1535-7163
  3. Doonan F, Cotter TG. (2008). Morphological assessment of apoptosis. Methods 44 (3): 200-204. doi: 10.1016/j.ymeth.2007.11.006 Funk JO (2005). Cell Cycle Checkpoint Genes and Cancer. Encyclopedia of Life Sciences. New York, NY, USA: John Wiley & Sons, Ltd. doi: 10.1038/npg.els.0006046 Kang HW, Muramatsu H, Lee BJ, Kwon YS (2010). Monitoring of anticancer effect of cisplatin and 5-fluorouracil on HepG2 cells by quartz crystal microbalance and micro CCD camera. Biosensors and Bioelectronics 26 (4): 1576-1581. doi: 10.1016/j. bios.2010.07.116 Kishimoto S, Yasuda M, Suzuki R, Fukushima S (2016). Intracellular uptake of an antitumor-active azole-bridged dinuclear platinum (II) complex in cisplatin-resistant tumor cells. Biometals 29 (6): 1075-1083. doi: 10.1007/s10534-016-9978-5
  4. Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65: 55-63. doi: 10.1016/0022-1759(83)90303-4
  5. Oztopcu-Vatan P, Sayitoglu M, Gunindi M, Inan E (2015). Cytotoxic and apoptotic effects of menadione on rat hepatocellular carcinoma cells. Cytotechnology 67 (6): 1003-1009. doi: 10.1007/s10616-014-9739-7
  6. Peyressatre M, Prével C, Pellerano M, Morris MC (2015). Targeting cyclin-dependent kinases in human cancers. Cancers 7 (1): 179-237. doi: 10.3390/cancers7010179 Sánchez-Martinez C, Gelbert LM, Lallena MJ, Dios A (2015). Cyclin dependent kinase (CDK) inhibitors as anticancer drugs. Bioorganic & Medicinal Chemistry Letters 25 (17): 3420-3435. doi: 10.1016/j.bmcl.2015.05.100 Shackelford RE, Kaufmann WK, Paules RS (1999). Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environmental Health Perspectives 107 (Su